We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
WEX to Benefit from benefitexpress Acquisition: Here's How
Read MoreHide Full Article
WEX Inc. (WEX - Free Report) yesterday announced that it has inked a deal to purchase benefitexpress for a sum total of nearly $275 million. The acquisition is expected to be neutral to the company’s adjusted net income in 2021. Subject to regulatory approvals and other customary closing conditions, the deal is expected to close during the second quarter of 2021.
benefitexpress is a provider of cloud-based benefits administration technologies and services. It has been a trusted partner of WEX’s Health division for many years.
Over the past six months, shares of WEX have gained 50.8% compared with 10.8% rise of the industry it belongs to.
How Will WEX Benefit?
benefitexpress is expected to expand WEX’s offerings in benefits administration by bringing in a complementary suite of solutions to WEX’s Health offerings, which includes enrollment and decision support tools for employees, benefits administration, and other value-added services, such as Affordable Care Act compliance, dependent verification services, and other benefit administration services. As a result, the deal should extend WEX’s health and employee benefits products and services across the employer clients.
Further, the deal is expected strengthen WEX’s competitive position within the public sector as well as among employers, brokers, and partners.
Notably, Robert Deshaies, president at WEX’s Health division, said, "The acquisition of benefitexpress accelerates our strategic vision of offering a complete healthcare ecosystem with a highly complementary benefits administration platform at its core." He further added, "We are excited to welcome the benefitexpress team to the WEX family and look forward to delivering increased value to employers, consumers, and partners through a comprehensive and integrated suite of products, services and technologies."
The long-term expected earnings per share (three to five years) growth rate for Accenture, Charles River Associates and Gartner is 10%, 13% and 14.7%, respectively.
More Stock News: This Is Bigger than the iPhone!
It could become the mother of all technological revolutions. Apple sold a mere 1 billion iPhones in 10 years but a new breakthrough is expected to generate more than 77 billion devices by 2025, creating a $1.3 trillion market.
Zacks has just released a Special Report that spotlights this fast-emerging phenomenon and 4 tickers for taking advantage of it. If you don't buy now, you may kick yourself in 2022.
Image: Bigstock
WEX to Benefit from benefitexpress Acquisition: Here's How
WEX Inc. (WEX - Free Report) yesterday announced that it has inked a deal to purchase benefitexpress for a sum total of nearly $275 million. The acquisition is expected to be neutral to the company’s adjusted net income in 2021. Subject to regulatory approvals and other customary closing conditions, the deal is expected to close during the second quarter of 2021.
benefitexpress is a provider of cloud-based benefits administration technologies and services. It has been a trusted partner of WEX’s Health division for many years.
Over the past six months, shares of WEX have gained 50.8% compared with 10.8% rise of the industry it belongs to.
How Will WEX Benefit?
benefitexpress is expected to expand WEX’s offerings in benefits administration by bringing in a complementary suite of solutions to WEX’s Health offerings, which includes enrollment and decision support tools for employees, benefits administration, and other value-added services, such as Affordable Care Act compliance, dependent verification services, and other benefit administration services. As a result, the deal should extend WEX’s health and employee benefits products and services across the employer clients.
Further, the deal is expected strengthen WEX’s competitive position within the public sector as well as among employers, brokers, and partners.
Notably, Robert Deshaies, president at WEX’s Health division, said, "The acquisition of benefitexpress accelerates our strategic vision of offering a complete healthcare ecosystem with a highly complementary benefits administration platform at its core." He further added, "We are excited to welcome the benefitexpress team to the WEX family and look forward to delivering increased value to employers, consumers, and partners through a comprehensive and integrated suite of products, services and technologies."
Zacks Rank and Stocks to Consider
WEX currently carries a Zacks Rank #3 (Hold). You can see the complete list of today’s Zacks #1 Rank (Strong Buy) stocks here.
Some better-ranked stocks in the broader Zacks Business Servicessector are Accenture (ACN - Free Report) , Charles River Associates (CRAI - Free Report) and TeleTech Holdings(TTEC - Free Report) , each carrying a Zacks Rank #2 (Buy).
The long-term expected earnings per share (three to five years) growth rate for Accenture, Charles River Associates and Gartner is 10%, 13% and 14.7%, respectively.
More Stock News: This Is Bigger than the iPhone!
It could become the mother of all technological revolutions. Apple sold a mere 1 billion iPhones in 10 years but a new breakthrough is expected to generate more than 77 billion devices by 2025, creating a $1.3 trillion market.
Zacks has just released a Special Report that spotlights this fast-emerging phenomenon and 4 tickers for taking advantage of it. If you don't buy now, you may kick yourself in 2022.
Click here for the 4 trades >>